• nPhase Mixes Data, Evidence in One Platform, N-Power Medicine, VieCure Enter Partnership, More

    Clinical Research News | nPhase launches the first industry platform to harmonize real-world evidence and clinical trial data in one system; N-Power Medicine and VieCure have entered a strategic partnership; and more.

    Sep 25, 2025

  • Follow the Money: Adjustment Disorder Clinical Trial, Solving Trial Recruitment Failure, More

    Clinical Research News | Reunion Neuroscience will continue with its ongoing REKINDLE Phase 2 clinical trial in Adjustment Disorder (AjD) in cancer; Trially has launched Margo, an agentic AI solution that multiplies trial enrollment by converting patient matches into participants; and more.

    Sep 24, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Building Momentum: Strengthening Patient Retention in Clinical Trials

    Clinical Research News | In clinical research, keeping patients engaged throughout the course of a trial is not only a logistical goal but a scientific necessity. Retention ensures that datasets remain complete, representative, and reliable. High dropout rates, by contrast, mean gaps in data, higher costs to backfill participants, and extended timelines that frustrate everyone involved.

    Sep 19, 2025

  • Psilocybin Shows Potential as Candidate for Delayed Aging

    Clinical Research News | Psilocybin—the psychoactive compound found in “magic mushrooms”—has often been viewed in a negative light due to the reputation of psychedelics, even among experts. But new research suggests that the compound could have a role in slowing the aging process.

    Sep 16, 2025

  • Tackling Trial and Data Complexity in DCTs with Advanced Analytics and Machine Learning

    Clinical Research News | Advanced statistical and machine learning (ML) models offer new ways to cope with an evolving and increasingly complex clinical trial data landscape. It enables us to interrogate new, complex and raw data sources, perform complex data reviews, learn from past studies and process large volumes of data.

    Sep 12, 2025

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts.

    Sep 10, 2025

  • New Microbiome-Derived Proteins Trials for Chronic Disease Treatment

    Clinical Research News | The gut microbiome has long been recognized as a key influencer of human health, but most clinical efforts to translate that knowledge have revolved around broad dietary interventions, probiotics, or microbial metabolites. Now, a team of researchers in Denmark is taking a new route that focuses on specific bacterial proteins that may directly regulate human metabolism and advancing them into clinical testing.

    Sep 9, 2025

  • LLMs Transform Clinical Trial Data Analysis with Human-Level Accuracy

    Clinical Research News | A study presented at the American Association for Cancer Research (AACR) conference reveals that large language models (LLMs) can match human experts in identifying critical cancer progression events from electronic health records—a development with significant implications for clinical trials and personalized medicine.

    Sep 4, 2025

  • Many Trials Testing Psychedelics for Treating Substance Abuse Disorders

    Clinical Research News | A resurgence of research interest in psychedelics over the past 25 years might soon see compounds like psilocybin, otherwise known as “magic mushrooms,” finally having their day. In the clinical trial setting, dozens of studies are now underway testing psychedelics for the treatment of post-traumatic stress disorder (PTSD), depression, and, perhaps most commonly, substance abuse disorders (SUDs).

    Sep 2, 2025

  • Study Cancellations Undercut Site Viability, Stakeholders Say

    Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution.

    Aug 28, 2025

  • Follow the Money: Supplying Global Clinical Trials, Novel Next-Gen Biosensor, More

    Clinical Research News | ARTBIO plans to rapidly advance its manufacturing network infrastructure to supply global clinical trials and commercialization, as well as their pipeline of alpha radioligand therapies; Sava Technologies will accelerate regulatory approval and commercialization of its next-generation wearable; and more.

    Aug 27, 2025

  • International Progressive MS Alliance Launches Data Platform, N-Power Launches Novel Platform, More

    Clinical Research News | The International Progressive MS Alliance launched its MS Clinical and Imaging Data Resource (CIDR); N-Power Medicine announced the launch of the industry’s first Prospective External Control Arm (ProECA) platform; and more.

    Aug 26, 2025

  • Navigating the Complexities of Radiopharmaceutical Therapy Trials

    Clinical Research News | Radiopharmaceutical therapy (RPT) has been around for a long time now, but advances in technology and understanding of the actionable molecular pathways that drive cancer have fueled a resurgence in interest and investment in the therapeutic modality. he popularity of RPTs is driven largely by theranostics combining diagnostic imaging and targeted therapy into a single, integrated system to more precisely deliver radiation to tumor cells and thereby minimize damage to healthy tissue.

    Aug 21, 2025

  • Non-Invasive Medical Devices Show Clinical Promise Across Multiple Indications

    Clinical Research News | Clinical trials and preclinical studies are demonstrating the therapeutic potential of Openwater's infrared light and low-intensity focused ultrasound technologies across a diverse range of medical conditions, from cancer treatment to stroke diagnosis.

    Aug 19, 2025

  • Latin America the ‘Hidden Gem’ for First-in-Human Medical Device Trials

    Clinical Research News | The big holdup in the development of advanced medical devices seems inevitably to happen at the point where first-in-human clinical trials are to begin, at least if the studies are to be conducted in the U.S. where it can be difficult to find clinical leaders, recruit patients, and bear the overall financial burden of their execution.

    Aug 14, 2025

  • Regulatory Proposals Good Match to Priorities of New FDA

    Clinical Research News | Regardless of how one views the priorities of the Food and Drug Administration (FDA) under the new administration, it’s an opportunity for badly needed change to “shake things up,” according to Doug Bain, founder and consulting partner of UK-based ClinFlo, a newly launched consulting and service company focused on the application of technology to improve clinical research.

    Aug 13, 2025

  • How Non-Profits Are Contributing to the Clinical Research Landscape

    Clinical Research News | The clinical research landscape is undergoing a significant transformation, with nonprofit organizations emerging as pivotal players in accelerating drug development for rare diseases. In the most recent episode of the Scope of Things podcast, Annette Bakker, CEO of the Children's Tumor Foundation (CTF), shared insights into how nonprofits are revolutionizing the clinical research ecosystem.

    Aug 12, 2025

  • Five Clinical Trends Shaping the Future of TMF Strategy

    Clinical Research News | The trial master file (TMF) is the backbone of clinical trials, ensuring completeness of documentation and compliance for studies. Yet, TMF is still perceived as a file repository. Biopharma and CRO leaders are advancing their approach to make TMF a more strategic tool for study management and oversight.

    Aug 8, 2025

  • Fluorescence-Guided Surgery Shows Promise in Clinical Trials for Cancer Detection

    Clinical Research News | Researchers are making significant strides in fluorescence-guided surgery, with dozens of glowing molecular probes currently under investigation in clinical trials to help surgeons better visualize tumor margins during operations. The technology could revolutionize surgical precision and eventually enable autonomous robotic surgery.

    Aug 5, 2025